Related Experiment Video

Updated: Aug 9, 2026

Genome-Wide Mapping of Histone Modifications and Transcription Factor Binding Sites in Neuroendocrine Small Cell Lung Cancer Cell Lines Using CUT&RUN
11:50

Genome-Wide Mapping of Histone Modifications and Transcription Factor Binding Sites in Neuroendocrine Small Cell Lung Cancer Cell Lines Using CUT&RUN

Published on: April 3, 2026

Aberrant methylation of RASGRF2 and RASSF1A in human non-small cell lung cancer

Hong Chen1, Makoto Suzuki, Yohko Nakamura

  • 1Division of Thoracic Diseases, Chiba Cancer Center, Nitona, Chiba 260-8717, PR China.

Oncology Reports
|April 6, 2006
PubMed

Insights

Aberrant methylation of RASGRF2, a tumor suppressor gene, is frequent in non-small cell lung cancer (NSCLC) and restores expression upon demethylation, suggesting a distinct role in carcinogenesis compared to RASSF1A.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Aberrant promoter methylation of tumor suppressor genes (TSGs) is implicated in carcinogenesis.
  • RASSF1A is a well-studied TSG in lung cancer, while RASGRF2's role is less understood, primarily investigated in pancreatic cancer.

Purpose of the Study:

  • To determine the methylation profile of RASGRF2 in lung cancer.
  • To compare the methylation profiles of RASGRF2 with RASSF1A in lung cancer.
  • To investigate the association between RASGRF2 methylation and gene expression.

Main Methods:

  • Reverse transcription PCR (RT-PCR) for RASGRF2 expression analysis.
  • Methylation-specific PCR (MSP) for aberrant methylation detection.
  • Treatment with 5-aza-2'-deoxycytidine to assess demethylation effects.
  • Analysis of primary non-small cell lung cancer (NSCLC) and corresponding non-malignant tissues.

Main Results:

  • Loss of RASGRF2 expression was observed in 36% of lung cancer cell lines.
  • Aberrant RASGRF2 methylation was found in 30% of NSCLC and 25% of small cell lung cancer (SCLC) cell lines.
  • RASGRF2 expression was restored after demethylating agent treatment.
  • RASGRF2 and RASSF1A methylation occurred in 34% and 39% of primary NSCLC, respectively, versus minimal methylation in non-malignant tissue.
  • No correlation was found between RASGRF2 and RASSF1A methylation status or clinical characteristics.

Conclusions:

  • Frequent methylation and silencing of RASGRF2 contribute to non-small cell lung cancer (NSCLC) development.
  • RASGRF2 methylation plays a role in NSCLC carcinogenesis, distinct from RASSF1A.
  • RASGRF2 represents a potential therapeutic target in NSCLC.

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...